Metabolic Fingerprint in Childhood Acute Lymphoblastic Leukemia

Area of Science:

• Biochemistry
• Pediatric Oncology
• Metabolomics

Background:

• Acute lymphoblastic leukemia (ALL) is a common childhood cancer.
• Understanding ALL's metabolic underpinnings is crucial for improving treatment and prognosis.
• The role of intermediary metabolism in ALL pathogenesis requires further investigation.

Purpose of the Study:

• To investigate the metabolomic fingerprint of children with ALL at diagnosis and post-induction therapy.
• To compare the metabolic profiles of ALL patients with healthy controls.
• To identify metabolic differences between ALL subtypes and treatment time points.

Main Methods:

• Prospective case-control study involving 34 children with ALL and 34 matched controls.
• Targeted analysis of 106 plasma and urinary metabolites at diagnosis (D0) and end of induction (D33).
• Multivariate and univariate statistical analyses using SIMCAP and R programming language.

Main Results:

• Distinct metabolomic differences were observed between ALL patients and controls at both D0 and D33.
• Significant variations in metabolic fingerprints were found between common B-ALL and pre-B ALL subtypes.
• Metabolic profiles changed significantly from D0 to D33, indicating treatment effects on metabolism.
• Key metabolic alterations involved fatty acid metabolism, amino acid metabolism, glycerophospholipid metabolism, and the glutaminolysis/TCA cycle.

Conclusions:

• Pediatric ALL exhibits distinct, time-dependent metabolic alterations.
• These metabolic changes may serve as potential prognostic biomarkers.
• Identifying these metabolic shifts could lead to novel therapeutic targets for ALL.